The Limits Of Todays GLP-1 Boom GLP-1 use has exploded and is expected to grow further as prices fall, and new options emerge, including oral versions such as the Wegovy pill developed by Novo Nordisk
Common gastrointestinal effects include nausea, diarrhea, vomiting, and constipation, which typically resolve as your body adjust
NICE guidance (CG189: Obesity: identification, assessment and management) recommends that weight-management interventions include: Dietary advice that promotes a balanced, varied diet rather than elimination of entire food groups
Your doctor should include recent lab work showing metabolic markers, a detailed weight history spanning at least the past 12 months, documentation of all lifestyle modification efforts with specific dates and outcomes, records of previous weight management medications tried and the reasons they were discontinued, and a Letter of Medical Necessity explaining why a GLP-1 medication is the appropriate next step for your care
Contraindications and precautions Medical contraindications: Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 contraindicate GLP-1 receptor agonist use
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis
